Related Experiment Videos
[Hormonal and biochemical parameters in postmenopausal osteoporosis]
E B Dourador1, V de Falco, W H Chahade
1Disciplina de Reumatologia, Faculdade de Medicina, Universidade de São Paulo-FMUSP.
Revista Do Hospital Das Clinicas
|March 1, 1997
Summary
Postmenopausal bone loss is linked to higher follicle-stimulating hormone (FSH) and lower oestradiol levels. Calcium and parathyroid hormone (PTH) levels did not show significant differences in this study.
Area of Science:
- Endocrinology
- Bone Metabolism
- Menopause Research
Context:
- Postmenopausal bone loss, or calcium negative balance, is a significant health concern.
- Previous studies on calciotropic and gonadotropic hormones' roles have yielded varied results.
- Understanding these hormonal influences is crucial for managing osteoporosis.
Purpose:
- To investigate the relationship between specific biochemical markers and postmenopausal bone loss.
- To analyze the correlation between gonadotropic hormones (FSH, oestradiol) and calciotropic hormones (PTH) with bone mineral density.
- To evaluate seric and urinary calcium levels in relation to postmenopausal bone loss.
Summary:
- This study analyzed 187 women aged 40-80, categorized by WHO criteria (normal, osteopenia, osteoporosis).
- Results indicate that decreased bone mineral density correlates significantly with elevated follicle-stimulating hormone (FSH) and reduced oestradiol levels (p < 0.00001).
- No significant differences were observed in seric/urinary calcium or parathyroid hormone (PTH) levels (p > 0.70).
Impact:
- Provides insights into the hormonal drivers of postmenopausal bone loss.
- Highlights the critical roles of FSH and oestradiol in bone density changes.
- Suggests that calcium and PTH levels may not be primary indicators in this context.